Sign Up
OverviewAPI
Bessemer Venture Partners' report reveals a decline in venture capital investment in the health tech sector, expected to decrease by 65% from 2021 to 2024. Despite this decline, the report emphasizes the industry's resilient founders and patient capital. It also highlights the potential rise of AI and the focus on streamlining the biopharma value chain.

Ask a question